| Peer-Reviewed

Optimizing Institutional Care of Implantable Intrathecal Drug Delivery Systems

Received: 21 February 2020     Accepted: 13 March 2020     Published: 31 March 2020
Views:       Downloads:
Abstract

Intrathecal drug delivery systems (IDDS) have been a valuable therapeutic modality in the treatment of intractable chronic pain, typically reserved for cases where conservative pain management has failed. Given the high risk of this treatment and infrequent encounters with IDDS, it is essential to develop an institutional process to ensure the safe and effective management of patients. Our multidisciplinary team utilized healthcare failure mode and effects analysis (HFMEA™) to identify risks and redundancies in our current processes, subsequently implementing changes to prevent them. Risks identified included: handwritten orders, no standard order set, manual drug calculations, poor identification of IDDS upon hospital admission, and scarce nursing documentation of intrathecal medication. Following this step, our team incorporated tools and technologies to manage the more complex IDDS patients: standard order sets, computerized physician order entry (CPOE) systems, and computerized clinical decision support (CCDS) systems. Also, an excel calculator was introduced—seemingly the first of its kind in clinical practice—thus making the process more unique, thorough, and safe. There is a large body of evidence supporting the use of computerized physician order entry systems (CPOE) to reduce medication errors, and providing access to a computerized clinical decision support system (CDDS) at the time of prescribing to improve outcomes in patient care. Incorporating these tools into the management of IDDS patients is a significant opportunity to reduce risks and improve patient outcomes.

Published in International Journal of Anesthesia and Clinical Medicine (Volume 8, Issue 1)
DOI 10.11648/j.ijacm.20200801.15
Page(s) 18-25
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2020. Published by Science Publishing Group

Keywords

Intrathecal, Pain Management, Quality Improvement, HFMEA

References
[1] Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol. 2001; 19 (9): 2542–2554.
[2] Wallace M and Yaksh TL. Long-term spinal analgesic delivery: A review of the preclinical and clinical literature. Reg Anesth Pain Med 2000; 25: 117-157.
[3] SQUIRE. Explanation and elaboration of SQUIRE 2.0 guidelines. 2015. http://www.squire-statement.org/index.cfm?fuseaction=page.viewpage&pageid=504 (accessed May 9, 2019).
[4] QI Essentials Toolkit: Failure Modes and Effects Analysis (FMEA) Tool. Institute for Healthcare Improvement; 2017. (Available on ihi.org).
[5] Deer TR, et al. Comprehensive Consensus Based Guidelines on the Intrathecal Drug Delivery Systems in the Treatment of Pain Caused by Cancer Pain. Pain Physician. 2011 May-Jun; 14 (3): E283-312.
[6] Deer et al. The Polyanalgesic Consensus Conference (PACC): Recommendations for Intrathecal Drug Deliver: Guidance for Improving Safety and Mitigating Risks. Neuromdulation 2017: 20: 155-176.
[7] Kosturakis BA, Gebhardt. Synchromed II Intrathecal Pump Memory Errors Due to Repeated Magnetic Resonance Imaging. Pain Physician. 2012 Nov-Dec; 15 (6): 475-7.
[8] Lee HM, Ruggo V, Graudins A. Intrathecal Clonidine Pump Failure Causing Acute Withdrawal Syndrome with “Stress-Induced” Cardiomyopathy. J Med Toxicol. 2016 Mar; 12 (1): 134-8. doi: 10.1007/s13181-015-0505-9.
[9] Stetkarova I, et al. Intrathecal Baclofen in Spinal Spasticity: Frequency and Severity of Withdrawal Syndrome. Pain Physician. 2015 Jul-Aug; 18 (4): E633-41.
[10] Lawson EF, Wallace MS. Advances in Intrathecal Drug Delivery. Curr Opin Anaesthesiol. 2012 Oct; 25 (5): 572-6. doi: 10.1097/ACO.0b013e3283572319.
[11] Knight KT, et al. Implantable Intrathecal Pumps for Chronic Pain: Highlights and Updates. Croat Med J. 2007 Feb; 48 (1): 22-34.
[12] Institute of Medicine (U.S.). (2001). Crossing the quality chasm: A new health system for the 21st century. Washington, D. C: National Academy Press.
[13] US Department of Health and Human Services. “HITECH Act Enforcement Interim Final Rule.” 2013. Available at https://www.hhs.gov/hipaa/for-professionals/special-topics/HITECH-act-enforcement-interim-final-rule/index.html (accessed March 13, 2017).
[14] Bates DW, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998; 280: 1311–6.
[15] Devine, E. B., et al. “Prescriber and Staff Perceptions of an Electronic Prescribing System in Primary Care: A Qualitative Assessment.” BMC Medical Informatics and Decision Making 10, no. 72 (2010): 72–83.
[16] Bates DW, et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 1999; 6: 313–21.
[17] Agrawal, A. Medication errors: prevention using information technology systems. Br J Clin Pharmacist 2009; 67 (6): 681-686. doi: 10.1111/j.1365-2125.2009.03427.
[18] Stultz, Nahata, MC. Computerized clinical decision support for medication prescribing and utilization in pediatrics. J Am Med Inform Assoc 2012; 19: 942–953. doi: 10.1136/amiajnl-2011-000798.
[19] Lehmann CU, Conner KG, Cox JM. Preventing provider errors: online total parenteral nutrition calculator. Pediatrics 2004; 113: 748e53.
[20] Lehmann CU, Kim GR, Gujral R, et al. Decreasing errors in pediatric continuous intravenous infusions. Pediatr Crit Care Med 2006; 7: 225e30.
[21] Institute of Safe Medication Practices. Guidelines for Standard Order Sets. 2010. Available at http://www.ismp.org/tools/guidelines/standardordersets.pdf (accessed March 13, 2017).
Cite This Article
  • APA Style

    Angela Kerins, Randall Knoebel, David Dickerson, Magdalena Anitescu. (2020). Optimizing Institutional Care of Implantable Intrathecal Drug Delivery Systems. International Journal of Anesthesia and Clinical Medicine, 8(1), 18-25. https://doi.org/10.11648/j.ijacm.20200801.15

    Copy | Download

    ACS Style

    Angela Kerins; Randall Knoebel; David Dickerson; Magdalena Anitescu. Optimizing Institutional Care of Implantable Intrathecal Drug Delivery Systems. Int. J. Anesth. Clin. Med. 2020, 8(1), 18-25. doi: 10.11648/j.ijacm.20200801.15

    Copy | Download

    AMA Style

    Angela Kerins, Randall Knoebel, David Dickerson, Magdalena Anitescu. Optimizing Institutional Care of Implantable Intrathecal Drug Delivery Systems. Int J Anesth Clin Med. 2020;8(1):18-25. doi: 10.11648/j.ijacm.20200801.15

    Copy | Download

  • @article{10.11648/j.ijacm.20200801.15,
      author = {Angela Kerins and Randall Knoebel and David Dickerson and Magdalena Anitescu},
      title = {Optimizing Institutional Care of Implantable Intrathecal Drug Delivery Systems},
      journal = {International Journal of Anesthesia and Clinical Medicine},
      volume = {8},
      number = {1},
      pages = {18-25},
      doi = {10.11648/j.ijacm.20200801.15},
      url = {https://doi.org/10.11648/j.ijacm.20200801.15},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijacm.20200801.15},
      abstract = {Intrathecal drug delivery systems (IDDS) have been a valuable therapeutic modality in the treatment of intractable chronic pain, typically reserved for cases where conservative pain management has failed. Given the high risk of this treatment and infrequent encounters with IDDS, it is essential to develop an institutional process to ensure the safe and effective management of patients. Our multidisciplinary team utilized healthcare failure mode and effects analysis (HFMEA™) to identify risks and redundancies in our current processes, subsequently implementing changes to prevent them. Risks identified included: handwritten orders, no standard order set, manual drug calculations, poor identification of IDDS upon hospital admission, and scarce nursing documentation of intrathecal medication. Following this step, our team incorporated tools and technologies to manage the more complex IDDS patients: standard order sets, computerized physician order entry (CPOE) systems, and computerized clinical decision support (CCDS) systems. Also, an excel calculator was introduced—seemingly the first of its kind in clinical practice—thus making the process more unique, thorough, and safe. There is a large body of evidence supporting the use of computerized physician order entry systems (CPOE) to reduce medication errors, and providing access to a computerized clinical decision support system (CDDS) at the time of prescribing to improve outcomes in patient care. Incorporating these tools into the management of IDDS patients is a significant opportunity to reduce risks and improve patient outcomes.},
     year = {2020}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Optimizing Institutional Care of Implantable Intrathecal Drug Delivery Systems
    AU  - Angela Kerins
    AU  - Randall Knoebel
    AU  - David Dickerson
    AU  - Magdalena Anitescu
    Y1  - 2020/03/31
    PY  - 2020
    N1  - https://doi.org/10.11648/j.ijacm.20200801.15
    DO  - 10.11648/j.ijacm.20200801.15
    T2  - International Journal of Anesthesia and Clinical Medicine
    JF  - International Journal of Anesthesia and Clinical Medicine
    JO  - International Journal of Anesthesia and Clinical Medicine
    SP  - 18
    EP  - 25
    PB  - Science Publishing Group
    SN  - 2997-2698
    UR  - https://doi.org/10.11648/j.ijacm.20200801.15
    AB  - Intrathecal drug delivery systems (IDDS) have been a valuable therapeutic modality in the treatment of intractable chronic pain, typically reserved for cases where conservative pain management has failed. Given the high risk of this treatment and infrequent encounters with IDDS, it is essential to develop an institutional process to ensure the safe and effective management of patients. Our multidisciplinary team utilized healthcare failure mode and effects analysis (HFMEA™) to identify risks and redundancies in our current processes, subsequently implementing changes to prevent them. Risks identified included: handwritten orders, no standard order set, manual drug calculations, poor identification of IDDS upon hospital admission, and scarce nursing documentation of intrathecal medication. Following this step, our team incorporated tools and technologies to manage the more complex IDDS patients: standard order sets, computerized physician order entry (CPOE) systems, and computerized clinical decision support (CCDS) systems. Also, an excel calculator was introduced—seemingly the first of its kind in clinical practice—thus making the process more unique, thorough, and safe. There is a large body of evidence supporting the use of computerized physician order entry systems (CPOE) to reduce medication errors, and providing access to a computerized clinical decision support system (CDDS) at the time of prescribing to improve outcomes in patient care. Incorporating these tools into the management of IDDS patients is a significant opportunity to reduce risks and improve patient outcomes.
    VL  - 8
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Department of Pharmacy, University of Chicago Medicine, Chicago, United States

  • Department of Pharmacy, University of Chicago Medicine, Chicago, United States

  • Department of Anesthesiology, Critical Care and Pain Medicine, Northshore University Healthsystem, Evanston, United States

  • Department of Anesthesia and Critical Care University of Chicago Medicine, Chicago, United States

  • Sections